MIR7-3HG

Across TCGA pan-cancer cohorts, MIR7-3HG Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR7-3HG data layer compared with 20 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher MIR7-3HG Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR7-3HG expression acts as an unfavorable survival marker.

THYM and UCEC are the cancer types where MIR7-3HG Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR7-3HG–THYM (OS)

Open the THYM breakdown →